Notice of updates
We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.
Read FSG
Notice of updates
We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.
Read FSG
HALO
The investment objective is to outperform the M.S.C.I ACWI Health Care Index over a three-year investment horizon. The portfolio is intended as a long-term investment with low stock turnover. It is reviewed and rebalanced (if required) quarterly.
Why invest in “Big Pharma”?
First, the pharmaceutical industry is typically less vulnerable to economic downturns, as people still need to purchase medications regardless of the state of the economy.
Additionally, the industry is known for its strong research and development capabilities, which can lead to the development of new, innovative drugs that can drive revenue growth for the company. Furthermore, the aging population in many developed countries is expected to drive increased demand for healthcare services, including pharmaceuticals, in the coming years. Investing in pharmaceutical companies can also provide a level of diversification to an investment portfolio, as the performance of these companies is not closely tied to the performance of other sectors.
Just recently, the efforts of Pfizer and AstraZeneca (and of course biotech Moderna) provided vaccines against one of the most serious pandemics that the world has sever seen. Merck’s revolutionary immune-oncology drug Keytruda is providing treatment for a wide variety of life threatening cancers, Eli Lilly and Novo Nordisk have brought forth revolutionary treatments for type 2 diabetes and obesity-a dual pandemic affecting the developed world. Bristol Myers successes in cardiology medications have improved the lives of thousands. The list goes on and on ad infinitum.
Not only do these large pharmaceutical companies have large and diverse revenue streams from existing treatments but they all have an extensive pipeline of potential indications in oncology, cardiology, auto-immune disease, central nervous system disorders as well as Alzheimer’s disease to name just a few.
Models are reviewed every 3 months and updated if necessary. We will notify you of changes, if any. You have the option to follow through and implement the changes in your Model, but we do not automatically rebalance on your behalf. Once you have purchased a Model, you have complete control over how the Model is managed, meaning you can decide to change the allocations to something that may better suit your personal circumstances, or remain invested in better performers over time.
We cannot provide you personal advice since we do not know your circumstances and are not licensed to do so.
However, we believe that investing in thematic Models should be part of a broad investment strategy, where exposure to Models gives your added diversification to your existing portfolio of assets.
HALO enables you to invest in portfolios of 10 shares each. Holding more shares reduces your risk relative to holding just a single company. This is because companies can operate in different parts across the value chain, in industries, and in different countries at different stages of the economic cycle. Each of these factors spreads out your risk so your portfolio becomes less sensitive to events in any one company, industry or geography.
The stock trading exchanges we work with may require a minimum trade amount, or minimum quantity per shares. When you purchase a Model, we will tell you what the minimum amount required is.
Unlike ETFs and managed funds, Models give you full transparency and you can add/remove shares in a Model. While we do recommend shares in Models and provide regular updates to the recommendations, we do not manage your portfolio for you. You will always be in full control of your investment.
When you invest in Models, you are the beneficial owner of the individual shares, unlike managed funds and ETFs. Hence you may also receive tax benefits since tax gains and losses are not shared with other investors in a pooled vehicle.
Also, unlike index tracking ETFs, we pick stocks that we believe are likely to outperform others with exposure to the theme.
HALO constructs Models designed around a theme using our in-house team of investment experts that have extensive experience in financial markets with institutions such as AMP, Perennial, Legal & General, Bank of America Merrill Lynch and Putnam Investments.
We also let users create and invest in their own Models.
A Model is a portfolio of 10 professionally-selected shares that align to a specific market, industry, trend, theme or investment style.
A Model is simply a basket of 10 professionally-selected shares that provides exposure to a specific market, industry, trend, theme or investment style, e.g.:
Unlike an ETF or managed fund, when you invest in a Model you are actually purchasing shares in the 10 recommended companies and therefore become the beneficial owner of the shares. This provides you a level of control and transparency not offered by ETFs and managed funds.
Models can been seen as an alternative to managed funds and ETFs, and may appeal to investors who wish to have more control and transparency when it comes to their investments.
Models offer the following features and benefits:
Exploring opportunities in the expanding markets driving the future of global economies.
Investing in the brands and behaviors shaping the way we live, work, and shop.
Investing in undervalued sectors and companies for steady, reliable returns.
Backing the breakthroughs redefining healthcare and changing lives worldwide.
How do we live in a greener, clearer and more sustainable world?
Harnessing disciplined, data-driven strategies to deliver reliable, long-term investment outcomes.
